Cell Biology Quiz: Western Blot Interpretation

20 questions · exam conditions

0:00

Western Blot InterpretationQuestion 1 of 20

A Western blot analysis of protein Y shows band intensities of 100 arbitrary units in control samples and 150 arbitrary units in experimental samples. However, the β-tubulin loading control shows 80 arbitrary units in control and 100 arbitrary units in experimental samples. What is the normalized fold-change in protein Y expression?

1.5-fold increase

1.2-fold increase

1.25-fold increase

0.8-fold decrease

No significant change

← Back to quizzes

Cell Biology Quiz

Cell Biology Quiz: Western Blot Interpretation

Practice Western Blot Interpretation in Cell Biology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Western Blot Interpretation, giving you a quick way to practice the rules, question types, and explanations that matter most for Cell Biology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

1.5-fold increase
1.2-fold increase (correct answer)
1.25-fold increase
0.8-fold decrease
No significant change

Explanation: When analyzing Western blot data, you must normalize protein expression levels against a loading control to account for differences in total protein loaded between samples. The loading control (like β-tubulin) should theoretically be constant, but experimental variation often occurs. To calculate normalized fold-change, you need to correct for loading differences using this formula:

\text{Normalized fold-change} = \frac{\text{Experimental protein Y}/\text{Experimental loading control}}{\text{Control protein Y}/\text{Control loading control}}

Plugging in the values:

\text{Normalized fold-change} = \frac{150/100}{100/80} = \frac{1.5}{1.25} = 1.2

This represents a 1.2-fold increase in protein Y expression. Choice A (1.5-fold increase) is the trap of using raw values without normalization—simply dividing 150 by 100. This ignores the fact that more total protein was loaded in the experimental lane, as evidenced by higher β-tubulin levels. Choice C (1.25-fold increase) incorrectly uses the loading control ratio (100/80 = 1.25) as if it were the protein change. Choice D (0.8-fold decrease) results from incorrectly inverting the calculation, perhaps dividing control by experimental values. Study tip: Always normalize Western blot data against loading controls. Raw band intensities are meaningless without accounting for loading differences. Remember: divide each protein value by its corresponding loading control, then compare those ratios between conditions.

Question 2

A researcher performs Western blot analysis for protein Z across four time points after drug treatment. The blot shows increasingly faint bands for protein Z over time, but the GAPDH loading control bands appear uniform across all lanes. What additional control would be most critical to validate the interpretation that protein Z levels decrease over time?

A second housekeeping protein like β-actin as an additional loading control
A positive control lane with known high levels of protein Z
A no-primary-antibody negative control to check for non-specific binding
Molecular weight markers to confirm protein Z identity
A drug vehicle control to rule out solvent effects on protein stability (correct answer)

Explanation: When interpreting Western blot results showing decreasing protein levels over time, you need to distinguish between actual protein degradation and experimental artifacts that could create the same pattern. The uniform GAPDH loading control suggests equal protein loading, but this doesn't rule out all potential confounding factors. The most critical missing control would be a vehicle-only treatment control - cells treated with the drug solvent but not the drug itself. This would definitively establish whether the decreasing protein Z levels are due to the drug treatment or simply time-dependent effects like cell death, media depletion, or normal protein turnover. Without this control, you can't conclude the drug is causing the protein decrease. Looking at the other options: Choice A (additional housekeeping protein) would be redundant since GAPDH already shows uniform loading. Choice B (positive control with high protein Z) confirms antibody function but doesn't address whether the decrease is drug-specific. Choice C (no-primary-antibody control) tests for non-specific secondary antibody binding, which wouldn't explain the time-dependent decrease pattern. Choice D (molecular weight markers) confirms protein identity but doesn't validate the interpretation of decreasing levels. The vehicle control is essential because many factors can cause protein levels to change over time in cell culture experiments. Always include appropriate negative controls that isolate the variable you're testing. For Western blots examining treatment effects over time, ask yourself: "How do I know this change is due to my treatment and not just the passage of time?"

Question 3

In a Western blot comparing protein expression between cell types A and B, the target protein shows a single sharp band at 60 kDa in cell type A but a broader, more diffuse band at the same molecular weight in cell type B. Both samples show equivalent loading controls. What is the most likely explanation for this difference?

Cell type B expresses a different isoform of the protein with altered sequence
The protein undergoes different post-translational modifications in cell type B (correct answer)
Cell type B has lower expression levels causing band spreading
There was uneven sample loading despite equivalent loading controls
The antibody has reduced specificity for the protein in cell type B

Explanation: When interpreting Western blot results, band appearance tells you as much about protein structure as band position tells you about molecular weight. A sharp, well-defined band indicates a homogeneous protein population, while a broad, diffuse band at the same molecular weight suggests structural heterogeneity within that protein. The key insight here is that both cell types show bands at 60 kDa, meaning the core protein is the same size, but the band quality differs dramatically. In cell type B, the broader band indicates the protein exists in multiple slightly different forms that migrate at nearly the same rate but create a "smeared" appearance. This is the classic signature of post-translational modifications like phosphorylation, glycosylation, or ubiquitination, which add small amounts of mass and can alter migration patterns slightly. Answer B correctly identifies this phenomenon. Answer A is incorrect because a different isoform would typically show a different molecular weight, not the same 60 kDa position. Answer C misunderstands band morphology—lower expression creates weaker bands, not broader ones. The band would be fainter but still sharp if the protein population were homogeneous. Answer D contradicts the given information that loading controls are equivalent between samples. Remember this pattern: same molecular weight + different band sharpness = post-translational modifications. Sharp bands mean uniform protein; diffuse bands mean the same protein with variable modifications. This distinction is crucial for interpreting Western blots in cell biology research.

Question 4

A Western blot shows two bands for protein X: one at 75 kDa and another at 150 kDa. The predicted molecular weight of protein X monomer is 75 kDa. Treatment with β-mercaptoethanol eliminates the 150 kDa band while intensifying the 75 kDa band. What does this result indicate about protein X?

Protein X forms covalent dimers through disulfide bonds between subunits (correct answer)
The 150 kDa band represents a non-specific antibody interaction
Protein X undergoes proteolytic cleavage that is prevented by reducing agents
The antibody recognizes both monomeric and aggregated forms equally well
β-mercaptoethanol causes protein X degradation from 150 kDa to 75 kDa

Explanation: When analyzing protein behavior on Western blots, pay attention to how different treatments affect band patterns—this reveals important structural information about protein complexes and their bonds. The key observation here is that β-mercaptoethanol treatment eliminates the 150 kDa band while intensifying the 75 kDa band. β-mercaptoethanol is a reducing agent that specifically breaks disulfide bonds (covalent bonds between cysteine residues). Since the predicted monomer size is 75 kDa and you see a 150 kDa band that disappears upon reduction, this indicates that two 75 kDa monomers were covalently linked through disulfide bonds to form a dimer. When these bonds are broken, the dimer dissociates into individual monomers, explaining why the 75 kDa band becomes more intense. Option A correctly identifies this disulfide-bonded dimer formation. Option B is wrong because non-specific antibody interactions wouldn't show this specific molecular weight relationship or respond predictably to reducing conditions. Option C incorrectly suggests proteolysis—but reducing agents don't prevent protein cleavage, and we'd expect different molecular weight patterns if cleavage were occurring. Option D misses the point entirely; the issue isn't antibody recognition efficiency but rather the structural relationship between the bands. Remember this pattern: when you see protein bands at multiples of a predicted molecular weight that disappear under reducing conditions, think disulfide-bonded oligomers. This is a common way cells regulate protein function through covalent modifications.

Question 5

In a Western blot time-course experiment, protein A levels are measured at 0, 2, 4, and 6 hours after treatment. The raw band intensities for protein A are 100, 120, 140, and 160 units, respectively. The corresponding β-actin loading control values are 100, 150, 175, and 200 units. At which time point does protein A show the highest normalized expression level?

0 hours (correct answer)
2 hours
4 hours
6 hours
Expression remains constant across all time points

Explanation: When analyzing Western blot data, you must always normalize protein levels against loading controls to account for variations in sample loading and transfer efficiency. Raw band intensities alone can be misleading if different amounts of protein were loaded in each lane. To find the highest normalized expression, calculate the ratio of protein A to β-actin at each time point:

0 hours: $\frac{100}{100} = 1.00$
2 hours: $\frac{120}{150} = 0.80$
4 hours: $\frac{140}{175} = 0.80$
6 hours: $\frac{160}{200} = 0.80$

The highest normalized expression occurs at 0 hours with a ratio of 1.00, making A correct. B, C, and D are all incorrect because they represent time points where protein A appears to increase in raw intensity, but when normalized against the loading control, the relative expression actually decreases to 0.80. These answers reflect the common trap of focusing only on raw band intensities without proper normalization. The β-actin values show that progressively more total protein was loaded at later time points (150, 175, and 200 units versus the baseline 100). This explains why protein A's raw values increased over time—not because protein A expression actually increased, but because more sample was loaded in each subsequent lane. Study tip: Always normalize Western blot data against loading controls before drawing conclusions about protein expression changes. Raw intensities can be deceiving when sample loading varies between lanes.

Question 6

A Western blot analysis reveals that protein B migrates at 40 kDa under non-reducing conditions but at 35 kDa under reducing conditions with DTT treatment. The predicted molecular weight based on amino acid sequence is 35 kDa. What is the most likely explanation for this migration difference?

Protein B contains intramolecular disulfide bonds that affect its gel migration (correct answer)
DTT treatment causes partial protein degradation reducing the apparent size
The protein forms intermolecular disulfide-linked complexes with other proteins
Post-translational modifications are removed by DTT treatment
The antibody recognizes different epitopes under reducing versus non-reducing conditions

Explanation: When you encounter Western blot questions involving reducing versus non-reducing conditions, focus on how protein structure affects migration through the gel. Proteins migrate based on their shape and size, not just molecular weight. Under non-reducing conditions, protein B migrates at 40 kDa despite having a predicted molecular weight of 35 kDa. When treated with DTT (a reducing agent that breaks disulfide bonds), it migrates at exactly 35 kDa—matching its predicted size. This pattern indicates that intramolecular disulfide bonds within the protein are creating a more compact, tightly folded structure that migrates slower through the gel, appearing larger than its actual molecular weight. Option A correctly identifies this phenomenon. Intramolecular disulfide bonds constrain protein folding, making the protein migrate differently than expected based on sequence alone. Option B is incorrect because DTT doesn't degrade proteins—it specifically reduces disulfide bonds. If degradation occurred, you'd see multiple smaller bands, not a single clean band at the predicted molecular weight. Option C describes intermolecular disulfide bonds between different proteins, but this would typically show the opposite pattern: larger complexes under non-reducing conditions that separate into individual proteins under reducing conditions. Option D is wrong because DTT specifically targets disulfide bonds, not other post-translational modifications like glycosylation or phosphorylation. These modifications would persist after DTT treatment. Study tip: Remember that reducing agents like DTT and β-mercaptoethanol break disulfide bonds. When you see migration differences between reducing and non-reducing conditions, think about disulfide bond effects on protein structure and mobility.

Question 7

In a comparative Western blot study, protein C shows identical band intensities in samples from conditions X and Y when probed with antibody A, but shows a 2-fold higher intensity in condition Y when probed with antibody B. Both antibodies target different epitopes of the same protein. What is the most likely explanation?

Antibody B has higher affinity for protein C than antibody A
Condition Y increases total protein C expression 2-fold
Condition Y causes a conformational change that exposes antibody B's epitope (correct answer)
Antibody A shows non-specific binding that masks expression differences
The loading controls were not properly normalized between conditions

Explanation: When analyzing Western blot data showing different results with two antibodies against the same protein, you need to consider what could cause antibody-specific differences in detection patterns. The key insight here is that both antibodies detect the same total amount of protein C under condition X, but only antibody B shows increased signal under condition Y. This suggests that condition Y doesn't change the total protein amount, but rather affects how accessible each antibody's specific binding site (epitope) is on the protein. Answer C correctly explains this pattern: condition Y likely causes a conformational change in protein C that exposes or makes more accessible the epitope recognized by antibody B, while leaving antibody A's epitope unchanged. This would result in identical signals for antibody A (since its epitope accessibility remains constant) but enhanced signal for antibody B (due to better epitope exposure). Answer A is wrong because if antibody B simply had higher affinity, it would show stronger signals than antibody A under both conditions, not just condition Y. Answer B is incorrect because if total protein expression increased 2-fold, both antibodies should detect this increase proportionally, giving higher signals for both. Answer D doesn't fit because non-specific binding by antibody A would create background noise but wouldn't explain why antibody B shows condition-specific changes while antibody A doesn't. Study tip: When you see differential antibody responses in Western blots, always consider protein conformation changes first. Different epitopes can have vastly different accessibility depending on the protein's folded state, making this a common experimental observation.

Question 8

In a Western blot analysis, protein E shows a single band at 60 kDa in control cells but two bands at 60 kDa and 65 kDa in cells treated with kinase inhibitors. The band intensities suggest the total amount of protein E remains constant. What is the most likely explanation for this pattern?

Kinase inhibitor treatment induces expression of a larger protein E isoform
The kinase inhibitor prevents phosphorylation, allowing detection of both forms (correct answer)
Protein E becomes hyperphosphorylated in response to kinase inhibition
The kinase inhibitor stabilizes protein E against degradation
Kinase inhibition causes protein E dimerization through non-covalent interactions

Explanation: When you encounter Western blot questions showing different banding patterns between treatments, focus on how post-translational modifications affect protein migration. Phosphorylation adds negatively charged phosphate groups to proteins, which can alter their electrophoretic mobility through the gel. In this case, the appearance of two bands (60 kDa and 65 kDa) when kinase inhibitors are used, compared to a single 60 kDa band in controls, reveals the true story. The kinase inhibitor prevents phosphorylation of protein E, allowing you to detect both the unphosphorylated (65 kDa) and any remaining phosphorylated (60 kDa) forms. The phosphorylated version migrates faster and appears at a lower apparent molecular weight because the added phosphate groups increase the protein's negative charge density, causing it to move more quickly through the gel matrix. Option A is incorrect because if a new isoform were being expressed, you'd expect increased total protein levels, not constant levels as described. Option C contradicts the data entirely – hyperphosphorylation would require active kinases, not kinase inhibition. Option D doesn't explain the molecular weight difference; protein stabilization would increase band intensity at the same molecular weight, not create a new band. The key insight is that kinase inhibitors reveal the protein's native, unmodified state by blocking the phosphorylation that normally occurs in control cells. This is why the correct answer is B. Remember: When Western blots show new bands appearing with enzyme inhibitors, think about what post-translational modification is being blocked and how that affects protein mobility.

Question 9

A student performs Western blot analysis on samples from three different cell lines (A, B, C) using the same antibody. The results show: Line A - single sharp band at 55 kDa; Line B - no detectable band; Line C - multiple bands at 55, 50, and 45 kDa. What is the most likely explanation for these different patterns?

Cell line B lacks the gene encoding this protein entirely
The antibody has different specificities depending on the cellular context
Cell lines express different splice variants and have different proteolytic activities (correct answer)
The protein loading was unequal between the three cell lines
Cell line A represents the normal state while B and C are abnormal

Explanation: When interpreting Western blot patterns, you need to consider what causes proteins to appear at different molecular weights and why detection might vary between cell lines. The key is analyzing both the presence/absence of bands and their size patterns. The correct answer is C because the results show classic signatures of biological protein variation. Cell line A's single 55 kDa band represents the full-length protein. Cell line B's lack of signal could result from very low expression levels, not necessarily gene absence. Most tellingly, cell line C's multiple bands at decreasing molecular weights (55, 50, 45 kDa) strongly suggests both splice variants (alternative mRNA processing creating proteins of different sizes) and proteolytic cleavage (enzymes cutting the protein into smaller fragments). Answer A is incorrect because complete gene absence would be unusual across standard cell lines, and you'd expect some evolutionary conservation. More importantly, low expression is more likely than total gene loss. Answer B misunderstands antibody function—the same antibody maintains consistent specificity regardless of cellular context; it binds the same epitope everywhere. Answer D doesn't explain the multiple bands in cell line C. Unequal protein loading would affect band intensity but wouldn't create the specific pattern of smaller molecular weight bands that suggest protein processing. Remember this pattern: multiple bands at decreasing molecular weights from a single antibody typically indicate protein processing (splicing, cleavage, or modification), not technical issues. Always consider biological explanations before technical ones when interpreting Western blot variations.

Question 10

A Western blot shows protein F at different molecular weights in cytoplasmic (48 kDa) versus mitochondrial (45 kDa) fractions from the same cell population. The predicted molecular weight of the mature protein is 45 kDa, and the signal peptide is predicted to be 3 kDa. What does this suggest about protein F?

Protein F undergoes different post-translational modifications in each compartment
The cytoplasmic form represents the precursor with its mitochondrial targeting sequence (correct answer)
There was cross-contamination between the cytoplasmic and mitochondrial fractions
Protein F exists as different splice variants targeted to different compartments
The molecular weight difference indicates different oligomerization states

Explanation: When you encounter Western blot data showing the same protein at different molecular weights in different cellular compartments, think about protein targeting and processing. This pattern often reveals how proteins are modified during their journey to specific organelles. The data tells a clear story: protein F appears as 48 kDa in the cytoplasm and 45 kDa in mitochondria, with the mature protein predicted to be 45 kDa and a 3 kDa signal peptide. This size difference of exactly 3 kDa between compartments matches the predicted signal peptide size perfectly. The cytoplasmic form represents the precursor protein still carrying its mitochondrial targeting sequence, while the mitochondrial form is the mature protein after signal peptide removal. This is exactly what answer B describes. Answer A is incorrect because different post-translational modifications wouldn't create such a precise 3 kDa difference that matches the predicted signal peptide size. Answer C (cross-contamination) doesn't explain why you'd see two distinct molecular weights rather than just one protein appearing in both fractions at the same size. Answer D is wrong because splice variants would show different sizes in the same compartment initially, and the 3 kDa difference specifically points to signal peptide processing, not alternative splicing. Remember this pattern: when you see a protein that's slightly larger in the cytoplasm than in an organelle, and the size difference matches a predicted targeting sequence, you're likely observing the precursor-to-mature protein processing pathway that's essential for proper protein localization.

Question 11

A researcher performs Western blot analysis on protein H and observes that the same samples run on different days show varying band intensities despite identical loading controls. Day 1 shows 100 units, Day 2 shows 150 units, and Day 3 shows 80 units for the same sample. What is the most likely cause and appropriate solution?

Protein degradation over time requires fresh sample preparation for each blot
Antibody degradation requires using fresh antibody dilutions for each experiment
Inconsistent transfer efficiency requires including transfer controls on each blot
Variable exposure times require standardizing imaging parameters across experiments (correct answer)
Gel-to-gel variation requires running all samples on the same gel simultaneously

Explanation: When analyzing Western blot variability, you need to systematically consider each step of the protocol to identify where inconsistencies might arise. The key clue here is that the same samples show dramatically different band intensities across different days despite identical loading controls, suggesting the issue occurs after protein separation and transfer. Answer D is correct because variable exposure times during imaging can easily cause the wide intensity differences observed (80-150 units). Western blot detection relies on chemiluminescent or fluorescent signals that decay over time, and different exposure durations will capture different amounts of signal. Without standardized imaging parameters—including exposure time, gain settings, and detection sensitivity—the same blot can appear drastically different between imaging sessions. Answer A is incorrect because protein degradation would typically show a progressive decrease over time, not the random fluctuation pattern seen here (100→150→80). Answer B is wrong because antibody degradation would similarly show consistent decline rather than the observed variability, and quality antibodies remain stable for months when properly stored. Answer C is incorrect because transfer efficiency problems would likely be detected by the loading controls, which the question states remain consistent. The most important study tip for Western blot troubleshooting: always standardize your imaging parameters first before suspecting sample or reagent issues. Create imaging protocols with fixed exposure times, and use the same settings across all experimental replicates. Many apparent "biological" differences in Western blots are actually technical artifacts from inconsistent detection methods.

Question 12

A Western blot analysis reveals protein I appears as a doublet (two closely spaced bands) at approximately 42 kDa in untreated cells. After treatment with alkaline phosphatase, only the lower band of the doublet remains visible. What is the most appropriate conclusion about protein I?

Protein I exists as two distinct splice variants with similar molecular weights
The upper band represents a phosphorylated form of protein I (correct answer)
Alkaline phosphatase treatment causes specific degradation of one protein form
The doublet represents different glycosylation states of protein I
Protein I forms homodimers that are disrupted by alkaline phosphatase

Explanation: When you encounter a Western blot showing a protein doublet that changes after enzyme treatment, you're looking at post-translational modifications. The key clue here is alkaline phosphatase treatment and the resulting band pattern. Alkaline phosphatase is a specific enzyme that removes phosphate groups from proteins. When protein I shows two bands initially but only the lower band remains after this treatment, it tells you that phosphorylation was causing the mobility shift. Phosphorylated proteins migrate more slowly through the gel due to their increased molecular weight and altered charge, appearing as the upper band. After dephosphorylation, only the unmodified protein remains visible as the lower band. This confirms that option B is correct. Let's examine why the other answers don't fit: Option A suggests splice variants, but splice variants wouldn't be affected by alkaline phosphatase treatment since they have different amino acid sequences, not just modifications. Option C proposes protein degradation, but alkaline phosphatase doesn't degrade proteins—it only removes phosphate groups, so you'd expect to see the same total protein amount, just shifted mobility. Option D suggests glycosylation differences, but alkaline phosphatase doesn't affect glycosylation states; you'd need different enzymes like glycosidases to test this. Remember this pattern: when you see a doublet that changes specifically after alkaline phosphatase treatment, with one band disappearing and the other remaining, you're almost certainly looking at a phosphorylation event. The slower-migrating band represents the phosphorylated form.

Question 13

A researcher observes that protein D appears as a single 45 kDa band in freshly prepared samples but shows additional lower molecular weight bands (35 kDa and 25 kDa) when samples are stored at 4°C overnight before analysis. The loading controls remain consistent. What is the most appropriate interpretation and solution?

The protein naturally exists in multiple isoforms that resolve better after overnight incubation
Protein D undergoes degradation during storage and protease inhibitors should be added (correct answer)
The antibody becomes more sensitive to different protein forms after overnight development
Temperature-dependent conformational changes alter the protein's migration pattern
The overnight storage allows complete protein extraction from cellular compartments

Explanation: When analyzing protein samples that show changes over time, you need to distinguish between genuine biological variation and technical artifacts like degradation. The key clue here is the appearance of smaller molecular weight bands after storage, combined with consistent loading controls. The correct interpretation is that protein D undergoes degradation during storage and protease inhibitors should be added (B). The pattern of a single 45 kDa band becoming multiple smaller bands (35 kDa and 25 kDa) is classic evidence of proteolytic cleavage. Proteases can remain active even at 4°C, slowly breaking down proteins into fragments. The consistent loading controls rule out sample loss or loading errors, confirming this is protein-specific degradation. Option A is incorrect because true isoforms would appear in fresh samples too - they wouldn't suddenly emerge after overnight storage. Option C misunderstands how antibodies work; antibody sensitivity doesn't change based on storage time, and the researcher is likely using the same detection method for both timepoints. Option D is wrong because temperature-dependent conformational changes wouldn't create discrete bands at lower molecular weights - they might shift migration slightly, but wouldn't produce the fragmentation pattern observed. For cell biology exams, remember that when you see progressive appearance of smaller protein bands over time, especially during sample storage, think proteolytic degradation first. Always consider adding protease inhibitor cocktails to prevent this artifact, particularly when working with protein extracts that will be stored before analysis.

Question 14

A student performs Western blot analysis and obtains the following densitometry values: Target protein in Lane 1: 200 units, Lane 2: 300 units; β-actin loading control in Lane 1: 150 units, Lane 2: 200 units. If Lane 1 represents the control condition, what is the correctly normalized fold-change for Lane 2?

1.5-fold increase
1.33-fold increase
1.125-fold increase (correct answer)
2.0-fold increase
0.89-fold decrease

Explanation: When analyzing Western blot data, proper normalization is crucial because variations in protein loading between lanes can create misleading results. The loading control (like β-actin) accounts for these differences by providing a reference protein that should be expressed consistently across samples. To calculate normalized fold-change, you first determine the ratio of target protein to loading control for each lane, then compare these ratios. For Lane 1 (control): 200 ÷ 150 = 1.33. For Lane 2: 300 ÷ 200 = 1.5. The fold-change is Lane 2's ratio divided by Lane 1's ratio: 1.5 ÷ 1.33 = 1.125, representing a 1.125-fold increase. Answer A (1.5-fold) represents the common error of simply dividing raw target protein values (300 ÷ 200 = 1.5) without normalizing to the loading control. This ignores the fact that Lane 2 had more total protein loaded. Answer B (1.33-fold) incorrectly uses only the loading control values (200 ÷ 150 = 1.33), completely ignoring the target protein data. Answer D (2.0-fold) likely results from incorrectly calculating the difference between lanes rather than the ratio, or from some other mathematical error in the normalization process. Remember this two-step approach for Western blot quantification: first normalize each lane's target protein to its loading control, then calculate the fold-change by comparing these normalized values. Never compare raw densitometry values directly—always account for loading differences first.

Question 15

A researcher performs Western blot analysis to detect protein X in cell lysates from treated and untreated conditions. The blot shows strong bands for protein X in both conditions, but the loading control (β-actin) shows a band that is 3x stronger in the treated condition compared to the untreated condition. What is the most appropriate conclusion about protein X levels?

Protein X levels increased 3-fold in the treated condition
Protein X levels remained unchanged between the two conditions
Protein X levels decreased 3-fold in the treated condition (correct answer)
The experiment is inconclusive due to loading control variation
Protein X levels increased slightly in the treated condition

Explanation: Western blot analysis requires careful interpretation of both your target protein and loading control to draw valid conclusions about protein expression changes. The loading control (like β-actin) serves as an internal standard to normalize for differences in protein loading between lanes. When you see that β-actin is 3x stronger in the treated condition, this tells you that 3x more total protein was loaded in that lane compared to the untreated condition. Even though protein X bands appear equally strong in both conditions, you must normalize for this loading difference. If equal amounts of protein had been loaded, the treated condition would show only 1/3 the protein X signal, indicating a 3-fold decrease in protein X levels. Looking at each option: Answer A incorrectly ignores the loading control entirely, focusing only on the apparent equal band intensities. Answer B makes the same error, concluding no change based solely on similar band strengths without accounting for the unequal loading. Answer D suggests the experiment is invalid, but loading control variations are exactly why we include them – to detect and correct for these differences. Answer C correctly recognizes that when you normalize the protein X signal to the loading control, the treated condition actually shows reduced protein X levels. Study tip: Always examine both your target protein AND loading control together in Western blots. The key formula is: relative protein level = (target protein signal)/(loading control signal). Never interpret Western blot results based on target protein bands alone.

Question 16

A student performs Western blot analysis using two different antibodies against the same target protein on identical samples. Antibody 1 (against N-terminus) shows bands at 50 kDa and 30 kDa, while Antibody 2 (against C-terminus) shows only the 50 kDa band. What is the most likely explanation for this difference?

Antibody 2 has lower sensitivity than Antibody 1 for detecting the protein
The 30 kDa band represents a C-terminal truncation product of the protein (correct answer)
Antibody 1 shows non-specific cross-reactivity with an unrelated 30 kDa protein
The 30 kDa band represents an N-terminal truncation product of the protein
Both antibodies are detecting the same protein fragments with different affinities

Explanation: When interpreting Western blot results with different antibodies against the same protein, you need to think about which parts of the protein each antibody can detect and what protein modifications might be present. The key insight here is understanding protein truncation patterns. If a full-length 50 kDa protein gets cleaved, the resulting fragments will contain different epitopes depending on where the cleavage occurs. An N-terminal antibody recognizes sequences at the protein's beginning, while a C-terminal antibody recognizes sequences at the protein's end. Since both antibodies detect the 50 kDa band, this represents the full-length protein containing both N- and C-terminal regions. However, only the N-terminal antibody detects the 30 kDa band, which means this smaller fragment must contain the N-terminus but lack the C-terminus. This pattern indicates the 30 kDa band is a C-terminal truncation product—the protein was cleaved somewhere in the middle, removing the C-terminal portion that Antibody 2 recognizes. Therefore, B is correct. A is wrong because both antibodies detect the 50 kDa band equally well, showing comparable sensitivity. C is incorrect because if Antibody 1 showed non-specific binding, you'd expect it to recognize proteins unrelated to your target, but the 30 kDa band appears to be a legitimate fragment of the same protein. D reverses the logic—an N-terminal truncation would be detected by the C-terminal antibody, not the N-terminal one. Remember: when analyzing Western blots with multiple antibodies, map out which protein regions each antibody recognizes to interpret fragment patterns correctly.

Question 17

A researcher compares protein levels between cytoplasmic and nuclear fractions using Western blot. The target protein shows strong bands in both fractions, but the cytoplasmic marker (β-tubulin) appears faintly in the nuclear fraction, while the nuclear marker (lamin B1) appears strongly only in the nuclear fraction. How should this data be interpreted?

The target protein is exclusively nuclear with cytoplasmic contamination artifacts
The target protein is present in both compartments but nuclear levels may be overestimated (correct answer)
The fractionation was successful and the target protein is truly present in both compartments
The experiment is invalid due to cross-contamination between fractions
β-tubulin contamination indicates the target protein's cytoplasmic localization is artifactual

Explanation: When interpreting subcellular fractionation data, you need to assess both the purity of your fractions and the distribution of your target protein. The key is analyzing what the marker proteins tell you about contamination levels. Looking at the marker proteins: β-tubulin (cytoplasmic marker) appears faintly in the nuclear fraction, indicating some cytoplasmic contamination of the nuclear prep. However, lamin B1 (nuclear marker) appears only in the nuclear fraction, showing the cytoplasmic fraction is clean. This pattern suggests the nuclear fraction contains some cytoplasmic material. Since your target protein shows strong bands in both fractions, but the nuclear fraction has cytoplasmic contamination, the nuclear signal likely includes both genuine nuclear protein plus contaminating cytoplasmic protein. This makes answer B correct - the protein is present in both compartments, but nuclear levels may be overestimated due to contamination. Answer A is wrong because the protein clearly appears in the cytoplasmic fraction, which is pure based on the markers. Answer C incorrectly assumes perfect fractionation when the β-tubulin contamination indicates otherwise. Answer D overreacts to minor contamination - the experiment provides useful data despite imperfect separation, since contamination is only in one direction and can be accounted for. Study tip: In fractionation experiments, always evaluate marker protein patterns first to assess fraction purity before interpreting your target protein's distribution. Minor contamination doesn't invalidate results but affects quantitative interpretation.

Question 18

In a Western blot experiment, a student observes multiple bands for a single protein target: a strong band at 50 kDa, a weaker band at 45 kDa, and a faint band at 25 kDa. The protein's predicted molecular weight based on sequence is 50 kDa. Which interpretation most likely explains this banding pattern?

The antibody is detecting three different proteins with similar sequences
The 50 kDa band represents the full-length protein while smaller bands are degradation products (correct answer)
All three bands represent different splice variants of the same gene
The multiple bands indicate antibody cross-reactivity with unrelated proteins
The 25 kDa band is a dimer formation while others are monomers

Explanation: When analyzing Western blot results with multiple bands, you need to consider the relationship between band sizes and the predicted molecular weight. The key insight is recognizing patterns that suggest protein processing or degradation versus genuine protein variants. The correct interpretation is B. The 50 kDa band matches the predicted full-length protein size exactly, indicating this is your target protein intact. The smaller bands at 45 kDa and 25 kDa represent degradation products - fragments created when the protein is partially broken down by proteases during sample preparation, storage, or even naturally within cells. The decreasing band intensity from 50 → 45 → 25 kDa supports this degradation pattern, as you'd expect less degraded protein than intact protein. Option A is incorrect because if these were different proteins with similar sequences, you wouldn't expect such a clear size progression or the exact match to your predicted molecular weight. Option C misinterprets splice variants - while alternative splicing can create size differences, the 50 kDa band matching your prediction exactly, combined with the smaller fragments, points to degradation rather than alternative gene products. Option D suggests random cross-reactivity, but the systematic size relationship and intensity pattern indicate specific detection of your target protein and its fragments. Study tip: In Western blots, when you see a main band at the expected size plus smaller bands, think "degradation" first. If you see multiple bands all near the expected size, consider splice variants or post-translational modifications.

Question 19

In a Western blot dose-response experiment, protein G levels are measured after treatment with increasing concentrations of compound X (0, 10, 50, 100 μM). The raw band intensities are 100, 150, 200, 250 units respectively, while β-actin controls show 120, 150, 180, 200 units. What is the fold-change between 0 μM and 100 μM treatments after proper normalization?

2.5-fold increase
2.08-fold increase
1.5-fold increase (correct answer)
1.67-fold increase
3.0-fold increase

Explanation: When you encounter Western blot quantification problems, the critical step is proper normalization using loading controls like β-actin. This accounts for variations in protein loading between lanes, ensuring accurate comparison of your target protein levels. To solve this, you need to normalize each protein G measurement by dividing it by its corresponding β-actin control. For 0 μM treatment:

\frac{100}{120} = 0.833

. For 100 μM treatment:

\frac{250}{200} = 1.25

. The fold-change is then:

\frac{1.25}{0.833} = 1.5

-fold increase. Looking at the wrong answers: Choice A (2.5-fold) represents the raw ratio without normalization (

\frac{250}{100} = 2.5

), ignoring the loading control entirely. Choice B (2.08-fold) appears to use an incorrect normalization approach, possibly averaging the β-actin values rather than using paired controls. Choice D (1.67-fold) might result from normalizing only one condition or using improper mathematical operations. The correct answer is C (1.5-fold increase), which properly accounts for loading differences revealed by the β-actin control. Remember this key principle: always normalize Western blot data using your loading control before calculating fold-changes. Raw band intensities can be misleading due to loading variations. The formula is: normalize each lane (target protein ÷ loading control), then calculate the ratio between conditions. This approach ensures your quantification reflects actual protein level changes rather than experimental artifacts.

Question 20

A Western blot experiment comparing drug-treated versus control cells shows the following results: Target protein - Control: 80 units, Treated: 200 units; β-actin loading control - Control: 100 units, Treated: 160 units; Total protein stain - Control: 120 units, Treated: 180 units. Which normalization approach would give the most accurate fold-change calculation?

Using β-actin normalization: 1.56-fold increase
Using total protein normalization: 1.67-fold increase (correct answer)
Using raw values without normalization: 2.5-fold increase
Both β-actin and total protein give equivalent results
The experiment cannot be properly normalized due to inconsistent controls

Explanation: When interpreting Western blot results, proper normalization is crucial because protein loading can vary between samples. You need to account for differences in total protein loaded to get accurate fold-change measurements of your target protein. The key insight here is recognizing when your loading control itself has changed between conditions. Let's examine the data: β-actin increased from 100 to 160 units (1.6-fold), while total protein increased from 120 to 180 units (1.5-fold). This indicates that the drug treatment affected overall protein synthesis or cell size, making β-actin an unreliable loading control. Using total protein normalization gives the most accurate result. The target protein's normalized values are: Control = 80/120 = 0.67, Treated = 200/180 = 1.11. The fold-change is 1.11/0.67 = 1.67-fold increase, making answer B correct. Answer A is flawed because β-actin normalization (80/100 = 0.8 vs 200/160 = 1.25, giving 1.56-fold) uses a loading control that was itself affected by the treatment. Answer C fails entirely by ignoring loading differences—the raw 2.5-fold increase partially reflects the 50% increase in total protein loading rather than true target protein upregulation. Answer D is wrong because the two normalization methods clearly give different results (1.56 vs 1.67). Remember: when your usual loading control (like β-actin) changes between conditions, total protein staining provides a more reliable normalization standard. Always check whether your loading control is truly unchanged before using it.